Cat.#: ACPP-1258
| Despition | Pannexin 1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1726 | Human Midkine Protein (AC1726) | 5 µg | inquiry |
| ACPP-1361 | PAX2 Blocking Peptide (AC1361) | 250 µg | inquiry |
| ACPP-1812 | Human IMPA1 Protein (AC1812) | 5 µg | inquiry |
| ACPP-1242 | MC3 Receptor Blocking Peptide (AC1242) | 250 µg | inquiry |
| ACPP-1545 | Human YWHAG Protein (AC1545) | 5 µg | inquiry |
| ACPP-1038 | Recombinant Human VCAM1 Protein (6×His Tag) (AC1038) | 50 µg | inquiry |
| ACPP-1773 | Human LIN28 Protein (AC1773) | 2 µg | inquiry |
| ACPP-1086 | Synthetic Nanodisc Human Somatostatin Receptor 2 Protein (AC1086) | 10 µg | inquiry |
| ACPP-1700 | Human SOX2 Protein, PolyR (AC1700) | 2 µg | inquiry |
| ACPP-1690 | Human PDE6H Protein (AC1690) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.